Internal Medicine, Hematology & Oncology · West Hills, CA
NPI
1972774958
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7320 Woodlake Avenue #330
West Hills, CA, 91307
Phone (818) 346-1773
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
123,024 services
Medicare patients, 2024
678
Average age 77
Drug cost, 2024
$6.6M
1,540 prescriptions
Company payments, 2025
$10K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher S Ho was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 22,440 times for 19 patients. In total Christopher S Ho billed 123,024 services in 122 codes, and Medicare paid $2.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 22,440 | 19 | $0.27 | $6,143 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,224 | 11 | $44.42 | $454K |
| J0897 Injection, denosumab, 1 mg | Office | 7,055 | 26 | $20.03 | $141K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,700 | 34 | $16.05 | $59K |
| 85025 Blood Count | Office | 1,881 | 447 | $7.60 | $14K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,830 | 28 | $0.09 | $163 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,688 | 20 | $0.07 | $123 |
| 80053 Clinical Chemistry | Office | 1,420 | 420 | $10.33 | $15K |
| 36415 Venipuncture Blood Collection | Office | 1,175 | 411 | $8.64 | $10K |
| 99214 Office E&M - Established | Office | 1,083 | 273 | $115.92 | $126K |
| 99213 Office E&M - Established | Office | 835 | 270 | $80.51 | $67K |
| 82784 Immunoassay | Office | 663 | 76 | $9.04 | $5,992 |
| 83540 Clinical Chemistry | Office | 496 | 232 | $6.31 | $3,128 |
| 83550 Clinical Chemistry | Office | 495 | 232 | $8.52 | $4,219 |
| 82728 Clinical Chemistry | Office | 469 | 225 | $13.29 | $6,231 |
By year: 2022 $1.5M for 126,569 services; 2023 $2.0M for 143,428 services; 2024 $2.7M for 123,024 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,881 | 447 | $7.60 | $14K |
| 80053 Clinical Chemistry | 1,420 | 420 | $10.33 | $15K |
| 36415 Venipuncture Blood Collection | 1,175 | 411 | $8.64 | $10K |
| 82784 Immunoassay | 663 | 76 | $9.04 | $5,992 |
| 83540 Clinical Chemistry | 496 | 232 | $6.31 | $3,128 |
| 83550 Clinical Chemistry | 495 | 232 | $8.52 | $4,219 |
| 82728 Clinical Chemistry | 469 | 225 | $13.29 | $6,231 |
| 82746 Clinical Chemistry | 229 | 153 | $14.41 | $3,300 |
| 82232 Clinical Chemistry | 215 | 125 | $15.72 | $3,381 |
| 82607 Clinical Chemistry | 214 | 147 | $14.65 | $3,136 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher S Ho prescribed most often to Medicare patients was Anastrozole, with 117 prescriptions and refills. In total Christopher S Ho wrote 1,540 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 117 | 349 | 36 | $3,027 |
| Eliquis Apixaban | 97 | 163 | 28 | $94K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 96 | 96 | 16 | $1,346 |
| Dexamethasone Generic | 49 | 59 | 14 | $1,156 |
| Ondansetron Odt Ondansetron | 45 | 45 | 23 | $373 |
| Hydroxyurea Generic | 44 | 115 | 11 | $1,202 |
| Jakafi Ruxolitinib Phosphate | 42 | 42 | Under 11 | $759K |
| Revlimid Lenalidomide | 40 | 40 | Under 11 | $702K |
| Morphine Sulfate Er Morphine Sulfate | 36 | 36 | Under 11 | $402 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 34 | 34 | Under 11 | $209 |
| Xgeva Denosumab | 34 | 34 | Under 11 | $102K |
| Procrit Epoetin Alfa | 32 | 32 | 11 | $109K |
| Triamcinolone Acetonide Generic | 31 | 31 | 14 | $400 |
| Keytruda Pembrolizumab | 28 | 28 | Under 11 | $305K |
| Allopurinol Generic | 28 | 74 | Under 11 | $144 |
Brand drugs: 577 claims; generic drugs: 963 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher S Ho $10K ($10K in general payments such as food, travel and fees) from 33 companies. The largest payer was Amgen Inc. with $6,986.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $6,986 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $453 |
| Genentech USA, Inc. ROG.SW | 12 | $219 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $213 |
| Astellas Pharma US Inc 4503.T | 6 | $168 |
| Janssen Biotech, Inc. JNJ | 6 | $156 |
| Gilead Sciences, Inc. GILD | 7 | $151 |
| EMD Serono, Inc. MRK.DE | 4 | $129 |
| Merck Sharp & Dohme LLC MRK | 4 | $104 |
| Sobi, Inc SOBI.ST | 3 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.